ACOR Financial Facts
Net loss per share-basic (earnings per share): -0.28Interest income: 46K
See Full Income Statement
Total assets: 1.32B
Intangible assets, net of accumulated amortization: 749.42M
See Full Balance Sheet
Acorda Therapeutics, Inc. (ACOR) Earnings
|
Expand Research on ACOR
Next EPS Date | N/A | EPS Growth Rate | -139.7% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | -188.2% | Revenue Growth Rate | +63.1% *Last Qtr. |
Average % Move 1-Wk after EPS | -8.4% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/4/19 | Q319 | -$0.46 | -$0.51 | +$0.05 | $47.7M | $44.72M | = | Details | |||
10/22/15 | Q315 | $0.31 | $0.15 | +$0.16 | $148.2M | $115.52M | N/A | Details | |||
10/31/18 | Q318 | $0.17 | -$0.02 | +$0.19 | $142.81M | $82.81M | = | Details | |||
5/2/19 | Q119 | -$0.56 | -$0.94 | +$0.38 | $44.14M | $33.04M | = | Details | |||
8/2/18 | Q218 | $1.40 | $0.72 | +$0.68 | $153.3M | $138.63M | = | Details | |||
7/28/16 | Q216 | $0.07 | $0.18 | -$0.11 | $127.5M | $128.33M | N/A | Details | |||
7/30/15 | Q215 | $0.31 | $0.17 | +$0.14 | $105.5M | $110.84M | N/A | Details | |||
10/30/14 | Q314 | $0.28 | $0.05 | +$0.23 | $106M | $94.7M | N/A | Details |